# Phase 2C.2 Ablation Variant: ER-OFF (Mito-only)
# Tests that inference doesn't hallucinate ER events when ER mechanism is disabled
# Expected: Predicted ER fraction ≤ 10% in all regimes

# Global settings (same as 2C.2)
global:
  seed: 44  # Different seed to avoid identical RNG sequence
  cell_line: "A549"
  total_wells_per_regime: 48
  vessel_type: "384-well"
  working_volume_ml: 50.0
  initial_confluence: 0.0
  initial_count: 50000

# Extended observation window
timepoints:
  - 0.0
  - 12.0
  - 24.0
  - 48.0
  - 72.0
  - 96.0
  - 120.0

# Metrics (both ER and mito observable, but only mito mechanism active)
metrics:
  - cell_count
  - viability
  - confluence
  - er_stress
  - mito_dysfunction

# Four regimes (same design, but all events will be mito-driven)
regimes:
  # ER-dominant (should produce NO events because ER is disabled)
  er_dominant:
    plate_id_prefix: "PlateA"
    n_wells_per_dose: 12
    doses:
      - compound: "tunicamycin"
        dose_uM: 0.130
        description: "Below ER threshold (but ER OFF)"
      - compound: "tunicamycin"
        dose_uM: 0.197
        description: "At ER threshold (but ER OFF)"
      - compound: "tunicamycin"
        dose_uM: 0.245
        description: "Above ER threshold (but ER OFF)"
      - compound: "tunicamycin"
        dose_uM: 0.300
        description: "Well above ER threshold (but ER OFF)"
    description: "ER-dominant regime: Should produce NO events (ER is OFF)"
    expected_mechanism: null  # No mechanism should fire

  # Mito-dominant (should produce mito events)
  mito_dominant:
    plate_id_prefix: "PlateB"
    n_wells_per_dose: 12
    doses:
      - compound: "rotenone"
        dose_uM: 0.5
        description: "Below mito threshold"
      - compound: "rotenone"
        dose_uM: 1.0
        description: "At mito threshold"
      - compound: "rotenone"
        dose_uM: 2.0
        description: "Above mito threshold"
      - compound: "rotenone"
        dose_uM: 4.0
        description: "Well above mito threshold"
    description: "Mito-dominant regime: All events should be mito (ER is OFF)"
    expected_mechanism: "mito"

  # Mixed (should produce only mito events, if any)
  mixed:
    plate_id_prefix: "PlateC"
    n_wells: 48
    compound_combo:
      - compound: "tunicamycin"
        dose_uM: 0.15
      - compound: "rotenone"
        dose_uM: 0.8
    description: "Mixed regime: Only mito events should occur (ER is OFF)"
    expected_mechanism: "mito"

  # Control (no events expected)
  control:
    plate_id_prefix: "PlateD"
    n_wells: 48
    compound: "dmso"
    dose_uM: 0.0
    description: "Control regime (no events expected)"
    expected_commitments: 0

# Ground truth: ER DISABLED
truth:
  # Phase 1 smooth REs
  phase1:
    enabled: true
    growth_cv: 0.10
    stress_sensitivity_cv: 0.08
    hazard_scale_cv: 0.12
    plate_level_fraction: 0.3

  # Phase 2A ER commitment (DISABLED)
  phase2a_er:
    enabled: false  # ← KEY DIFFERENCE
    threshold: 0.60
    baseline_hazard_per_h: 0.20
    sharpness_p: 2.0
    hazard_cap_per_h: 2.0
    committed_death_hazard_per_h: 0.50

  # Phase 2A Mito commitment (ENABLED)
  phase2a_mito:
    enabled: true
    threshold: 0.60
    baseline_hazard_per_h: 0.15
    sharpness_p: 2.5
    hazard_cap_per_h: 2.0
    committed_death_hazard_per_h: 0.50

# Acceptance criteria
acceptance:
  recovery:
    threshold_abs_error: 0.10
    sharpness_abs_error: 1.0
    baseline_hazard_log_factor: 3.0

  prediction:
    commitment_fraction_abs_error: 0.15

  attribution:
    min_accuracy_dominant_regimes: 0.80
    mechanism_split_abs_error: 0.20

  ablation:
    max_parameter_change_scrambled_labels: 0.05
    max_hallucinated_mechanism_fraction: 0.10  # ≤10% ER attribution allowed
